Patent 1: He has been the lead scientist and inventor of a novel and selective AT2R analogs presenting antitumor properties (patent WO 2013091883) with MRCT, LMB, Cambridge, UK. Our lab in 2014 was awarded a Development Gap Fund (DGF) from … Continue reading Patents